Comparing Actemra vs Tyenne
| Actemra (tocilizumab) | Tyenne (tocilizumab) |
|
|---|
| Actemra (tocilizumab) | Tyenne (tocilizumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Giant Cell Arteritis, Rheumatoid Arthritis, COVID-19, Cytokine Release Syndrome, Polyarticular Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis, Systemic... View more |
Prescription only
Prescribed for Giant Cell Arteritis, Rheumatoid Arthritis, COVID-19, Cytokine Release Syndrome, Polyarticular Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis. Tyenne may also be used for... View more |
Related suggestions Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Giant Cell Arteritis
Popular comparisons
|
|||||||||||||||
| More about Actemra (tocilizumab) | More about Tyenne (tocilizumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Actemra has an average rating of 6.7 out of 10 from a total of 49 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 24% reported a negative effect. |
Tyenne has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Actemra side effects |
View all Tyenne side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Actemra prices |
View all Tyenne prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other tocilizumab brands include: Avtozma, Tofidence, Tyenne | Other tocilizumab brands include: Actemra, Avtozma, Tofidence | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
210 hours |
210 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 425 drugs are known to interact with Actemra:
|
A total of 425 drugs are known to interact with Tyenne:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
January 08, 2010 |
March 05, 2024 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.